Objective: Atypical endometrial hyperplasia (AH) is the neoplastic precursor more often associated with endometrial cancer (EC). Nowadays, 25–50% of patients subjected to hysterectomy for preoperative AH are diagnosed with EC at the final pathological analysis. Furthermore, there is no consensus on which preoperative AH patients would benefit from sentinel lymph node mapping. This study aimed to evaluate nodal assessment and preoperative cancer risk factors in preoperative AH patients undergoing nodal surgical staging. Methods: Patients undergoing surgical treatment for AH were retrospectively included in the analysis. Patients were divided into two groups (AH and EC groups) based on the final surgical pathology. The ESGO/ESTRO/ESP risk classification was used for EC cases. Design: This was a retrospective study. Results: Of the 207 AH patients treated, 152 cases met the inclusion criteria. Among preoperative AH patients with final EC diagnosis, 39 patients were in the low-risk group (25.7%), 8 in the intermediate-risk group (5.3%), 4 in high-intermediate (2.6%), and 3 patients were allocated in the high-risk group (2.0%). Fifty-four total patients underwent nodal surgical staging. Only one nodal micrometastasis (0.7%) was found at ultrastaging. Multivariate analysis showed abnormal uterine bleeding (AUB) (p = 0.01), hypertension (p < 0.01), and endometrial thickness ≥20 mm (p = 0.02) statistically more represented in patients with EC at final surgical analysis. EC risk was 2.9 (95% CI: 1.29–6.48) in AUB, 2.7 (95% CI: 1.06–6.92) in hypertension, and 3.1 (95% CI: 1.19–7.97) in endometrial thickness ≥20 mm cases. Limitations: The present study has limitations inherent in its retrospective nature. Conclusion: The overall risk of nodal metastases in preoperative AH patients was low. Conversely, 9.9% of the preoperative AH patients belonged to the intermediate or high-risk group for EC at the final histological examination. Preoperative cancer risk factors would identify AH patients for whom nodal staging could be suggested.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2020
.
CA Cancer J Clin
.
2020 Jan
;
70
(
1
):
7
30
. .
2.
Sobczuk
K
,
Sobczuk
A
.
New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
.
Prz Menopauzalny
.
2017
;
3
(
3
):
107
11
. .
3.
Baak
JP
,
Mutter
GL
,
Robboy
S
,
van Diest
PJ
,
Uyterlinde
AM
,
Orbo
A
,
The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system
.
Cancer
.
2005
;
103
(
11
):
2304
12
. .
4.
Lax
SF
.
New features in the 2014 WHO classification of uterine neoplasms
.
Pathologe
.
2016
;
37
(
6
):
500
11
. .
5.
Byun
JM
,
Jeong
DH
,
Kim
YN
,
Cho
EB
,
Cha
JE
,
Sung
MS
,
Endometrial cancer arising from atypical complex hyperplasia: the significance in an endometrial biopsy and a diagnostic challenge
.
Obstet Gynecol Sci
.
2015
;
58
(
6
):
468
74
. .
6.
Costales
AB
,
Schmeler
KM
,
Broaddus
R
,
Soliman
PT
,
Westin
SN
,
Ramirez
PT
,
Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia
.
Gynecol Oncol
.
2014 Dec
;
135
(
3
):
451
4
. .
7.
Horn
LC
,
Schnurrbusch
U
,
Bilek
K
,
Hentschel
B
,
Einenkel
J
.
Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment
.
Int J Gynecol Cancer
.
2004
;
14
(
2
):
348
53
. .
8.
Taşkın
S
,
Kan
Ö
,
Dai
Ö
,
Taşkın
EA
,
Koyuncu
K
,
Alkılıç
A
,
Lymph node dissection in atypical endometrial hyperplasia
.
J Turk Ger Gynecol Assoc
.
2017 Sep 1
;
18
(
3
):
127
32
. .
9.
Touhami
O
,
Grégoire
J
,
Renaud
MC
,
Sebastianelli
A
,
Grondin
K
,
Plante
M
.
The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia
.
Gynecol Oncol
.
2018 Mar
;
148
(
3
):
485
90
. .
10.
Touboul
C
,
Piel
B
,
Koskas
M
,
Gonthier
C
,
Ballester
M
,
Cortez
A
,
Factors predictive of endometrial carcinoma in patients with atypical endometrial hyperplasia on preoperative histology
.
Anticancer Res
.
2014
;
34
(
10
):
5671
6
.
11.
Matsuo
K
,
Ramzan
AA
,
Gualtieri
MR
,
Mhawech-Fauceglia
P
,
Machida
H
,
Moeini
A
,
Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia
.
Gynecol Oncol
.
2015 Nov
;
139
(
2
):
261
7
. .
12.
Gungorduk
K
,
Ozdemir
A
,
Ertas
IE
,
Sahbaz
A
,
Asicioglu
O
,
Gokcu
M
,
A novel preoperative scoring system for predicting endometrial cancer in patients with complex atypical endometrial hyperplasia and accuracy of frozen section pathological examination in this context: a multicenter study
.
Gynecol Obstet Invest
.
2015
;
79
(
1
):
50
6
. .
13.
Volpi
L
,
Sozzi
G
,
Capozzi
VA
,
Ricco’
M
,
Merisio
C
,
Di Serio
M
,
Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience
.
Int J Gynecol Cancer
.
2019 Feb
;
29
(
2
):
312
9
. .
14.
Sozzi
G
,
Fanfani
F
,
Berretta
R
,
Capozzi
VA
,
Uccella
S
,
Buono
N
,
Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study: a multicentric analysis of predictors of failed mapping
.
Int J Gynecol Cancer
.
2020
;
30
(
11
):
1713
8
. .
15.
Concin
N
,
Matias-Guiu
X
,
Vergote
I
,
Cibula
D
,
Mirza
MR
,
Marnitz
S
,
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
.
Int J Gynecol Cancer
.
2021 Jan
;
31
(
1
):
12
39
. .
16.
Seif
MW
,
Diamond
K
,
Nickkho-Amiry
M
.
Obesity and menstrual disorders
.
Best Pract Res Clin Obstet Gynaecol
.
2015
;
29
(
4
):
516
27
. .
17.
National Comprehensive Cancer Network
.
Uterine neoplasms (Version 1.2021)
. Available from: https//www.nccn.org/professionals/physician_gls/pdf/uterine.pdf (accessed March 10, 2021).
18.
Sozzi
G
,
Uccella
S
,
Berretta
R
,
Petrillo
M
,
Fanfani
F
,
Monterossi
G
,
Tumor size, an additional risk factor of local recurrence in low-risk endometrial cancer: a large multicentric retrospective study
.
Int J Gynecol Cancer
.
2018 May
;
28
(
4
):
684
91
. .
19.
Whyte
JS
,
Gurney
EP
,
Curtin
JP
,
Blank
SV
.
Lymph node dissection in the surgical management of atypical endometrial hyperplasia
.
Am J Obstet Gynecol
.
2010 Feb
;
202
(
2
):
176.e1
4
. .
20.
Zorzato
PC
,
Bosco
M
,
Franchi
MP
,
Mariani
A
,
Cianci
S
,
Garzon
S
,
Sentinel lymph node for endometrial cancer treatment: review of the literature
.
Minerva Med
.
2021 Feb
;
112
(
1
):
70
80
. .
21.
Capozzi
VA
,
Riemma
G
,
Rosati
A
,
Vargiu
V
,
Granese
R
,
Ercoli
A
,
Surgical complications occurring during minimally invasive sentinel lymph node detection in endometrial cancer patients. A systematic review of the literature and metanalysis
.
Eur J Surg Oncol
.
2021 Aug
;
47
(
8
):
2142
9
. .
22.
Cianci
S
,
Rosati
A
,
Vargiu
V
,
Capozzi
VA
,
Sozzi
G
,
Gioè
A
,
Sentinel lymph node in aged endometrial cancer patients “the SAGE study”: a multicenter experience
.
Front Oncol
.
2021 Oct 19
;
11
:
737096
. .
23.
Pelligra
S
,
Scaletta
G
,
Cianci
S
,
Gueli Alletti
S
,
Restaino
S
,
Fagotti
A
,
Update on new imaging technologies in sentinel node detection
.
Minerva Ginecol
.
2020
;
72
(
6
):
404
12
. .
24.
Chen
YL
,
Wang
KL
,
Chen
MY
,
Yu
MH
,
Wu
CH
,
Ke
YM
,
Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group
.
J Gynecol Oncol
.
2013
;
24
(
1
):
14
20
. .
25.
Soler
M
,
Chatenoud
L
,
Negri
E
,
Parazzini
F
,
Franceschi
S
,
la Vecchia
C
.
Hypertension and hormone-related neoplasms in women
.
Hypertension
.
1999 Aug
;
34
(
2
):
320
5
. .
26.
Bjørge
T
,
Stocks
T
,
Lukanova
A
,
Tretli
S
,
Selmer
R
,
Manjer
J
,
Metabolic syndrome and endometrial carcinoma
.
Am J Epidemiol
.
2010
;
171
(
8
):
892
902
. .
27.
Aune
D
,
Sen
A
,
Vatten
LJ
.
Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies
.
Sci Rep
.
2017
;
7
(
1
):
44808
. Erratum in: Sci Rep. 2018;8:46961. .
28.
Bangalore
S
,
Kumar
S
,
Kjeldsen
SE
,
Makani
H
,
Grossman
E
,
Wetterslev
J
,
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324, 168 participants from randomised trials
.
Lancet Oncol
.
2011
;
12
(
1
):
65
82
. .
29.
Furberg
AS
,
Thune
I
.
Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort
.
Int J Cancer
.
2003
;
104
(
6
):
669
76
. Erratum in: Int J Cancer. 2003;104(6):799. .
30.
Vetter
MH
,
Smith
B
,
Benedict
J
,
Hade
EM
,
Bixel
K
,
Copeland
LJ
,
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia
.
Am J Obstet Gynecol
.
2020
;
222
(
1
):
60.e1
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.